• North American business up 40 percent in Q1
• Track record of phenomenal domestic growth with international growth plan in place
• Zach’s pegs NETE at $3.12 per share once profitable

Currently trading at 65 cents a share, Zach’s Small Cap Research just pegged Net Element (NASDAQ: NETE) at $3.12, five times current market value, once it reaches profitability (http://dtn.fm/9vNVT). The highly respected research firm noted that Net Element’s U.S. business growth was up a phenomenal 40 percent in the first quarter, while the company’s overseas operations and expansion were currently dragging down growth. However, global expansion has been a cornerstone of Net Element’s long term growth plans.

Growth, the elixir of Wall Street, is no stranger to Net Element. Just last year, the company was recognized by the South Florida Business Journal as one of the fastest growing technology companies in the United States, and, in 2012, the company’s Unified Payments division was named the fastest-growing private company in America by Inc. Magazine. To become an industry leader, investing, opening and expanding into new markets is imperative to sustain growth trajectories over time.

A technology-driven mobile payments and transactional services company, Net Element’s products and services include mobile payments, value-added services, marketing solutions and business analytics. Through its wholly owned group of companies, Net Element’s global divisions support electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce and mobile devices. The company provides turn-key services, including the technology and services required for cashless transactions, to small and medium-sized businesses throughout the United States and in select international markets.

Known for its dynamic marketing efforts, Net Element’s North American Unified Payments division continued its strong growth in Q1 2017 as the company added a record 1,500 merchants to its customer base. The company is aggressively adding new North American customers, and rapid customer acquisition is continuing into Q2.

Net Element’s international game plan is to spur global growth where it already has a substantial footprint by leveraging its omni-channel platform to deliver flexible offerings to select emerging markets with diverse banking, regulatory and demographic conditions, such as the UAE, Kazakhstan, Kyrgyzstan and Azerbaijan. Net Element has already launched initiatives is these locations.

Given Net Element’s historic track record of phenomenal domestic growth, there’s no reason to doubt the company’s ability to grow internationally. Once Net Element kicks revenue in its international markets into high gear, profitability should be around the corner and Zach’s target of $3.12 per share should easily be in reach.

For more information, visit www.NetElement.com

• Launched world’s first Chinese language online CBD health products store
• Launched world’s first Chinese language mobile cannabis navigation app
• Positioned to become first company in China to use CBD oil in treating epilepsy and Alzheimer’s

Pursuing its aim of becoming the leading publicly traded Chinese medical marijuana company, ChineseInvestors.com, Inc. (OTCQB: CIIX) continues its focus on investing in distribution and R&D of cannabidiol-based (CBD) medicines and health products targeted at Chinese-speaking clients throughout the world.

Marijuana use is currently illegal in China, but cannabis-based oils, including hemp-based CBD, are legal, giving CIIX access to a market of almost two billion potential customers in that country. CIIX is also expanding its footprint to other countries and recently incorporated CBD Biotechnology Inc. in British Columbia, Canada, which will focus on R&D and distribution of health products, including hemp-based CBD, food and beverage products there.

Additionally, CIIX officially launched a CBD online store, ChineseCBDoil.com, in December 2016 in the free-trade zone of Shanghai, China. The site went live on January 31 and is the very first CBD health products Web store to be launched in the Chinese language, offering various CBD nutritional products, such as soft gels, capsules and concentrates. The company further plans to market a line of nutrition and food products through a brick-and-mortar store in San Gabriel, California — a predominantly Chinese-speaking area and the company’s home market (http://dtn.fm/HcS2S).

Concurrent with the launch of ChineseCBDoil.com, CIIX also launched the very first Chinese language mobile cannabis navigation app, which is a Yelp-style social media app containing a database of cannabis dispensaries and marijuana strains. The app also features a platform for reviewing and discussing cannabis products, maps showing marijuana dispensary locations, and summary reports of cannabis businesses in Los Angeles and other large cities. This app has already been approved by the Apple store.

CIIX’s other cannabis-related endeavors include striving to become the very first company in China to employ CBD oil as a treatment to relieve suffering for epilepsy and Alzheimer’s patients. The company plans to continue studying CBD oil’s efficacy as a treatment for these diseases and intends to invest in CBD drug R&D enterprises, with an end goal of developing a variety of CBD drugs to treat epilepsy and Alzheimer’s.

For more information, visit the company’s website at www.ChineseInvestors.com

Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board

• A 1,000-fold increase in the Canadian cannabis oil extraction market is expected, with growth from C$1 million in 2015 to an expected C$1.7 billion by 2020
• The Canadian market is expected to see a conversion rate of 45 percent, which is similar to trends in Colorado, based on a Mackie Research Capital study
• The Government of Canada expects to fully legalize marijuana nationwide on or before July 2018

Investors have had their eyes on Algae Dynamics Corp. (OTCQB: ADYNF), which has partnered with various Canadian universities (including the University of Waterloo and Western University) for access to research and to boost its cannabis extraction expertise. The company is now positioned to serve the medical and recreational marijuana markets. However, many are surprised to learn that, as legalization of recreational marijuana is set for July 2018, Charles Sousa, Ontario’s finance minister, has warned of a possible supply shortage.

The company has had at the core of its product development strategy the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA, which is an important nutrient for brain, eye, and heart health, as well as the creation of various associated nutraceutical products. In light of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, the company has developed a strategy aimed at developing new products combining the health benefits of algae and cannabis oils.

In a Bloomberg Politics article (http://dtn.fm/r2Ne5), an analyst suggested a supply shortage could give the government an excuse to delay the country’s marijuana program, even as the cannabis oil extraction market grows toward the billion-dollar mark. Government officials, however, have made it clear they want a supply that’s able to accommodate demand to bring down organized crime and illicit drug use. The initial plan is expected to allow sales of cannabis online and via mail.

The reasons for a potential shortage include difficulty in stocking enough inventory nationwide, expanding patient lists, and producers selling out of strains or refusing to take on new clients. In Canada, the number of registered medical marijuana users tripled in one year, and the medical market is already seeing shortages. Health Canada announced in May that it would expedite the license approval process. New licenses have been issued, but it can take a year or more for businesses to build up production. Recent studies have shown a 45 percent conversion rate (users of dry marijuana switching to cannabis oil products) in Colorado, which is anticipated in Canada as well. Licensing and expertise will be needed to meet this demand.

Despite uncertainties, demand and research and development in the cannabis market continue to surge. As Algae Dynamics aims to be the leader in cannabis oil research in Canada, it continues to pursue the compound as a treatment for conditions such as colorectal, breast, pancreatic, and prostate cancers, and for other conditions such as post-traumatic stress disorder, schizophrenia, anxiety, and depression. The company itself will submit a licensing application to Health Canada, so it can produce medical marijuana and sell cannabinoid-derived products. Its knowledge and cultivation know-how enables production of an algae biomass that is free of contaminants and high in healthy Omega-3 fatty acids.

The management, fundraising, process, and commercialization experience of the Algae Dynamics team has positioned the company for rapid growth. Despite the threat of a legalized marijuana supply shortage, the company is working hard with researchers, developers, and investors in a market that encompasses all of Canada and that extends well beyond the country’s borders.

For more information about the company’s research efforts and development process, go to www.AlgaeDynamics.com

Let us hear your thoughts: Algae Dynamics Corp. Message Board

• HCPA (subsidiary) possesses the technical expertise to source, implement, and distribute at-profit reclaimed water.
• AES (subsidiary) provides off the shelf and custom designed treatment technologies across customer base that contribute to HCPA’s business model of low-cost treatment and distribution.
• Gilbert (subsidiary) eyeing investment opportunities within the Marcellus and Utica regions (PA, OH, and WV areas). With Gilbert as an owner and producer of energy sources in the region, it and each competitor is a potential customer for AEPI services.

Converde Energy USA, Inc. (OTC: XFUL), d/b/a American Energy Partners, Inc., may not be walking on water, but its management has created a business model that looks likely to pull off a miracle. Based in Pennsylvania, American Energy Partners, Inc. (AEPI) and its subsidiaries together comprise an integrated vertical that sources, scrubs, and supplies water to mining, oil and gas, power and other industrial concerns. Now producing half of oil output and two-thirds of gas output in the U.S., fracking is an industry that undoubtedly will require large volume providers like AEPI to keep its head above water.

Water plays an essential role in hydraulic fracturing (fracking), and a typical well requires about 4.4 million gallons. That’s the amount used by 11,000 American families every day. Most of that water (63%) comes from surface sources such as rivers; another substantial amount (20%) is purchased from public water utilities that source surface supplies and wells; almost as much (15%) is recycled treated flowback water from previously fracked wells; while the rest (2%) are the ‘active fracking ingredients’, consisting of proppants and chemicals. Proppants are the suspensions of sand that keep bedrock fissures open, allowing gas and oil to flow out. With about 4,475 locations still to be drilled between the Marcellus and Utica regions of Pennsylvania and Ohio, AEPI’s future as a water provider looks rosy. “The Utica and Marcellus shale natural gas plays based respectively in Ohio and Pennsylvania have provided 85-90% of U.S. shale gas production growth since start of 2012,” according to Forbes (http://dtn.fm/L2LEp).

AEPI’s triple play, comprising Hydration Company of PA (HCPA), American Energy Solutions, LLC (AES) and Gilbert Oil & Gas Company (Gilbert), integrates proprietary interests in water sources, design and treatment solutions, and marketing opportunities and business alliances.

The HCPA model implementation begins when hydrological studies are carried out to locate the largest pools of non-potable water, i.e., water that is not safe for drinking. Negotiations are then initiated with the current owners to gain access to these pools. After additional hydrological and engineering studies are performed and the required permits obtained, a filtration system is installed. Lastly, a dynamically-adjustable, turn-key platform goes online, allowing HCPA to distribute as required.

HCPA’s hands-on execution is backed up by sister subsidiary American Energy Solutions (AES). AES provides the technologies that HCPA uses to implement its strategy of providing cost-effective water treatment and distribution. AES plans to develop an in-house team with the ultimate aim of building market share in treatment technologies and the design of distribution methodologies. Meanwhile, AEPI plans to use Gilbert’s broad industry valuation experience to source drilling, operating, and partnership opportunities in the upstream oil and gas space. With so much going for it, AEPI seems to be offering investors in need of comfort a bridge over troubled water.

For more information, visit the company’s website at www.AmericanEnergy-Inc.com

Let us hear your thoughts: Converde Energy USA, Inc. Message Board

• ORHub is a cloud-based health care software that can help medical providers achieve cost efficiencies of 20-40% and drive closure of reimbursement gaps
• In real time, through Azure intelligence and analytics, it can analyze procedures, offer predictive analysis, and enable efficient procurement for hospital administrators
• It can develop fair pricing on bundled payments for providers and payers

ORHub, Inc. (OTC: ORHB), a health care software-as-a-service company, is primed to play an important role in delivering both cost reduction and actionable resource analytics tools in surgeries such as spinal, hip, knee, and cardiac catheter procedures, offering greatly improved resource allocation, real time monitoring of surgery, and predictive analysis using cloud-based software that delivers fact-based cost targets. The result: ORHub can help achieve cost reductions of from 20-40% in health care.

The value of this revolutionary system is illustrated by the experience of the Hoag Orthopedic Institute (HOI) in using ORHub to advance orthopedic care (http://dtn.fm/31EYx). HOI is successfully using the system to improve teamwork, automate manual processes, and better understand resource allocation in its spinal surgeries. The system, which runs on the Microsoft Azure platform, can play a critical part in achieving value-based models of health care. In spinal surgeries, it enables hospital administrators, through Azure intelligence and analytics, to offer real time digital review and reconciliation. In can generate accurate records which can be sent electronically to multiple entities, including medical device companies, hospital procurement, materials management, and billing departments. ORHub is on the frontline of new health care IT delivery. It is seen as both agile and scalable.

Wesley Mitchell, chief technology officer at ORHub, said, “When we have 50,000 procedures in the system, we can start to effect change in the healthcare world. That includes introducing predictive analysis that hospitals can use to anticipate what resources are necessary for a given type of procedure. This can also help healthcare providers and payers coordinate fair pricing on bundled payments.”

Mitchell added that the introduction of ORHub’s software into the medical field could result in cost reductions of from 20-40%. That’s significant, because U.S. health care costs are at more than $3 trillion annually, or 17% or the American GDP, per ORHub calculations.

“If we can achieve that with the cost of surgeries across the U.S. health system, that equates to USD $250-$350 billion saved every year. That’s greater than the gross domestic product of Finland,” Mitchell said.

He added that he started the project after being contacted by a surgeon about wanting software to help analyze resource allocation for surgical procedures. According to ORHub’s research, hospitals spend between 48-50% of their overall revenue on surgery. Mitchell’s interest was piqued, and the project was initiated.

For more information, visit the company’s website at www.ORhub.com

Let us hear your thoughts: ORHub, Inc. Message Board

• Compliant, protective, and blast-proof products can reduce damage at federal, state, and local facilities
• Barriers, revetments, fuel tank jackets, and blast protection equipment are suitable for customers in commercial and military market sectors
• New products or retrofits are available to customers requiring powerful blast protection and fire suppression systems

Blastgard International, Inc. (OTC: BLGA) is a manufacturer of proprietary blast mitigation products that meet the requirements of the Support Anti-terrorism by Fostering Effective Technologies Act of 2002 (SAFETY Act). Used by commercial, law enforcement, government, and military customers, the company’s blast-resistant and fire-suppressing materials provide the anti-terrorism protection specified under the Department of Homeland Security’s SAFETY Act. The legislation calls for technology that can be immediately deployed at public and private facilities, limit liability of anti-terrorism technology providers, and prevent a large-scale loss of life and economic impacts.

In addition, Blastgard’s products have been approved by the General Services Administration (GSA). This qualification streamlines procurement in that several federally-mandated contracting requirements are met. Being approved by the GSA means products such as BlastWrap® are differentiated in the market, so public and private agencies can have improved access to them. BlastWrap is on the DHS’s “Approved Products List for Homeland Security” and provides protection against strong explosions, ballistic materials, and fragments. Working indoors and outdoors, in wet/dry conditions and vented/unvented locations, it can protect property and people against solid explosives and fires caused by flammable liquids.

BlastWrap materials can be used in the cargo holds and containers of commercial aircraft, as building walls (to protect against vehicle bombs), and around fuel tanks to suppress explosions and fireballs. They have also been used on naval vessels and merchant ships, minimizing the impact from mines, torpedoes, and cruise missiles. Suitable as dividers on aircraft, ships, and offshore platforms to suppress fuel mist explosions and fireballs, the products have also been used in explosives manufacturing and handling facilities, propellant manufacturing plants, and fireworks plants as partitions and separators. Also, the company’s products have been implemented in underwater applications and entertainment industry sound stages.

The company also manufactures the Blastgard MTR Series of trash receptacles. These triple-wall containers can withstand improvised explosive devices, their fragments, and fires. Weatherproof and corrosion-resistant, the 35-gallon capacity receptacles can be customized with colors, artwork, logos, and powder coating. Each unit can resist over 4,000 pounds of horizontal and vertical force.

Usable in just about any industry, Blastgard’s products are in demand at a time when terror attacks occur on a regular basis. Recent events in Europe, including a bomb explosion at the Brussels Central train station on June 20 (http://dtn.fm/Rlxb8), warrant methods of protecting personnel and civilians with equipment that can withstand explosions and fires. The incident occurred just months after terror attacks killed over 30 people in the city. Additional events and heightened alerts demonstrate the need for protection when such potentially devastating incidents cannot be avoided.

For more information about BlastGard International, BlastWrap technology, and blast-proof products for commercial, military, law enforcement, and government segments, go to www.BlastgardIntl.com

Let us hear your thoughts: BlastGard International, Inc. Message Board

• Alzheimer’s is the most ominous and expensive disease in the U.S.
• IGC is the first and only NYSE MKT-listed pharmaceutical company to develop cannabis-based Alzheimer’s therapies
• IGC’s patent pending phytocannabinoid therapies to enter clinical trials for potential Alzheimer’s breakthrough

A pioneer in the development of innovative cannabis-based combination therapies, India Globalization Capital (NYSE MKT: IGC) is creating new classes of phytocannabinoid pharmaceuticals with broad therapeutic applications for both humans and animals. IGC’s pipeline of patent pending therapeutics include treatments for pain, cachexia, neurologic disorders, Parkinson’s and Alzheimer’s disease. IGC plans to enter clinical trials this year on its primary pipeline of four major therapeutics that address large market maladies. These trials include a potential cannabis-based blockbuster treatment for Alzheimer’s, America’s most ominous and expensive disease.

Alzheimer’s disease has no cure, no means of prevention and no long-term disease-modifying treatments. It’s a fatal, progressive brain disease that slowly destroys memory and thinking skills. It’s the third-leading cause of death in the U.S., following cancer and heart disease. More than 5.3 million Americans and over 46 million people worldwide are currently suffering from Alzheimer’s, and, frighteningly, this number is expected to triple within a few decades. Alzheimer’s is also the most expensive disease in the nation. In 2016, costs totaled $236 billion for the U.S., and global costs exceeded $600 billion. These figures will skyrocket if the disease continues unchecked.

Bolstering its portfolio of patent pending cannabis-based pharmaceuticals, IGC recently acquired exclusive rights to a novel THC-based treatment for Alzheimer’s disease from the University of South Florida (http://www.igcinc.us/alzheimers-disease/). Under the definitive license agreement with the university, IGC is the exclusive licensee of a patent filing for the use of tetrahydrocannabinol (THC) as a potential therapeutic agent for Alzheimer’s. The patent claims discovery of a new pathway in which low doses of THC bind to amyloid beta plaques and prevent those plaques from aggregating on neurons, which is exactly what occurs in Alzheimer’s disease and causes cognitive decline.

This new pathway holds immense potential in treating Alzheimer’s, and IGC will own the rights to this unprecedented therapeutic pathway if the patent is granted and proven. Acquiring this patent further supports IGC in protecting its proprietary formulation IGC-AD1, which includes low-doses of THC and is intended to disrupt the buildup of amyloid beta plaques and alleviate some of the worst symptoms of Alzheimer’s disease.

Several clinical studies are currently underway to address the ravages of Alzheimer’s, but later this year IGC will become the first and only company to utilize cannabis-based therapies for the treatment of the disease. Even though there are about a dozen publicly traded cannabis pharmaceutical stocks on the market, none have patent filings to a potential Alzheimer’s breakthrough.

Should IGC’s clinical studies show promise on Alzheimer’s or any of its primary pipeline of phytocannabinoid therapeutics, it could not only trigger a major shift in national medical marijuana policy but also dramatically impact the company’s market capitalization and stock price to the upside.

For more information, please visit http://www.igcinc.us

• Canadian Cannabis Valuations up 200% in two years
• 250 acres of cultivation space stretching from Alberta to Ontario
• Paid out $1,000,000 in Dividends representing $0.07 per Share

It might just be that Invictus MD Strategies Corp. (OTC: IVITF) (TSX.V: IMH) (FRA: 8IS) has adopted as a motto the elevating penultimate line from William Ernest Henley’s immortal poem Invictus: “I am the master of my fate”. Canada’s Cannabis Company appears completely unafraid as it ploughs ahead with its strategy to become a dominant company in Canada’s cannabis space. That boldness is paying off; Invictus is one of only a handful of cannabis companies declaring dividends. Now, with 250 acres of cultivation space stretching from Alberta to Ontario under management, Invictus is poised to deliver product to Canada’s medical and recreational marijuana markets, as Ottawa reiterates its determination to implement a legal framework for adult use by July 2018 (http://dtn.fm/yQG0j).

In executing that market domination strategy, Invictus’s management has pulled off some savvy deals since the company went public, under the symbol IMH, on the Canadian Securities Exchange (CSE) in December 2014. In March 2015, Invictus took up a 20 percent stake in hydroponic service company Future Harvest Development (FHD). Just four months later, it quickly increased that investment to acquire a majority holding and then sold off FHD’s Sunblaster Lighting division in February 2016. Those breathtaking developments provided a 216% return on investment; Sunblaster, sold for $2,850,000, had an acquisition cost of $900,000. Invictus now holds 82.5% of FHD.

Cannabis Health Sciences was another successful exit. The company, which publishes the Cannabis Health Journal, was bought for $45,000 and later sold for $230,000, earning Invictus a hefty return of 411 percent.

Invictus’ current portfolio companies have equal potential. Wholly-owned Acreage Farms of West-Central Alberta is currently valued at $34.5 million. The division received its cultivation license under the Access to Cannabis for Medical Purposes Regulations (ACMPR) on March 29, 2017, and is already operational. A 6,800 sq ft purpose built concrete and steel facility has already been constructed, and a planned expansion of 27,400 sq ft on the 150-acre property is imminent. Cultivation started in May 2017, and the unit is expected to reach output of 3,000 kg in 2018, 10,000 kg in 2019 and 25,000 kg by 2020.

In addition, together, associated companies AB Laboratories and AB Ventures are likely to do even better. Their joint production capacity is planned, by 2018, to hit 5,000 kg before climbing to 15,000 kg in 2019 and a level of 25,000 kg in 2020. AB Laboratories already has a cultivation license, received on October 21, 2016. The company, in which Invictus has a one-third stake, expects to get its sales license very soon and is currently valued at $30 million. Its facility in Hamilton, Ontario, covers about 16,000 sq ft.

AB Ventures is Invictus’s “startup” operation. The division closed a 100-acre acquisition in May 2017 and has filed an ACMPR pre-license application for that planned facility. It is aiming to develop 100,000 sq ft (about 2¼ acres) of cultivation and production space by 2019. The unit, in which Invictus also has a one-third stake, is valued at $22.5 million.

There is no doubt that halcyon days are ahead for Invictus. Valuations of cannabis companies have risen over 200 percent over the past two years, with some high fliers crossing the 300% mark. Valuations of ancillary businesses, those that supply services and equipment to the cannabis industry, are rising on the swell, too. Invictus was able to pay out a $1 million dividend to shareholders on December 5, 2016, representing $0.07 per share, because of its divestment of Sunblaster Lighting. With the Canadian recreational cannabis market projected to reach $6 billion, Invictus, now listed on the TSX-V under the symbol IMH, has a fate that looks decidedly promising.

For more information, please visit www.Invictus-MD.com

• Unique proprietary technology meeting growing and compelling global need
• HighCom Security division is the first company in the world to achieve BA 9000 certification
• Strong connections and sales history with DOD and DHS, as well as with law enforcement and commercial entities around the world

The rising incidence of terrorist attacks around the world is not being taken lying down. America’s police departments have taken note and are gearing up, literally, to defend the homeland. To do so, to protect their officers, they are relying increasingly on body armor and blast protection products, like those from BlastGard International, Inc. (OTC: BLGA). The Florida-headquartered company has developed a line of products to protect people and property from explosive blasts. It also provides products that offer protection from projectiles. BlastGard’s protective gear includes shields, helmets, vests and plates, which provide police with the protective gear they need to do their jobs.

With an estimated 750,000 police officers, America’s 17,000 law enforcement agencies require a lot of body armor, which, typically, has a life cycle of about five years. Combining this statistic with an average 10 percent attrition rate in law enforcement (about one in 10 officers leave every year) means that, every year, approximately 30 percent of body armor purchases are repeated. That results in a steady, vibrant market for BlastGard. In July 2014, its HighCom Security division, responsible for body armor, became the first company in the world to achieve BA 9000 certification. BA 9000, released in January 2012, extends ISO 9001 requirements to manufacturers of body armor vests for federal, state, local, tribal law enforcement and corrections bodies.

BlastGard’s HighCom Security business unit is a leader in advanced ballistic armor manufacturing. Operating from a 32,865 square foot manufacturing and distribution facility located in Columbus, Ohio, the division can handle large scale, time-sensitive global supply needs. Directed from the logistics center in Florida, the unit serves customers in North America, such as the Department of Defense and the Department of Homeland Security, local law enforcement agencies, correctional facilities, municipal authorities and large corporations, as well as others throughout the world. Past sales have been to Asia, Africa, Europe, Latin America, and the Middle East.

BlastGard’s body armor range is wide. It includes Type IIA body armor, which offers basic protection against smaller caliber handgun threats; Type II body armor, which provides protection against larger handguns, including many common smaller caliber pistols with standard pressure ammunition and against many revolvers; Type IIIA body armor, which can resist heavy pistol calibers including most law enforcement ammunition and many higher powered revolvers, and Type III and IV body armor, which provides protection against rifle rounds, generally only used in tactical situations.

BlastGard expects that, as police departments become more militarized, demand for its products and services will grow. As threats of all kinds multiply, there is mounting evidence of the emergence of a new kind of police officer, the Warrior Cop, resulting from the integration of tactical, SWAT, and special operations within the law enforcement environment. This trend is likely to fuel demand for body armor with higher protection levels and lower areal densities and designs that provide more mobility and comfort, including helmets. Areal density gives an indication of the energy absorption capability of the protective material and is computed as the weight of the armored panel in grams per square meter divided by the protection area of the panel.

The BlastGard Defense division offers BlastWrap®, a product that defuses the power of explosions and helps to suppress any fires caused by those explosions. The technology is composed of two integrated flexible films arranged one over the other and joined by a plurality of seams filled with attenuating filler material (volcanic glass bead or other suitable materials) with an extinguishing coating. It works by slowing the dissipation of energy triggered by an explosion, reducing the force of the blast and, consequently, the likelihood of fatalities. BlastGard is not only in the business of providing protection for individuals and property; it’s also in the business of saving lives.

For more information, visit the company’s website at www.BlastGardIntl.com

Let us hear your thoughts: BlastGard International, Inc. Message Board

• China’s economy is now world’s 2nd largest – set to overtake the U.S. this century
• 695 million+ mobile internet users create new Chinese consumer
• Moxian, Inc. (NASDAQ: MOXC) platforms convert online users to retail customers

The roots of modern capitalist China are curiously and inexorably linked to the 1949 foundation of the People’s Republic of China by communist revolutionary Mao Zedong. In spite of horrific atrocities, Mao is still credited for modernizing China and building it into a world power as China’s population grew from around 550 million to over 900 million under his leadership. Mao seized control of China after a brutal civil war and held power until his death in 1976. Many of his socialist policies such as promoting the status of women, improving education and health care, and increasing life expectancy actually integrate and underpin today’s Chinese economic model. Since inception, the People’s Republic of China has surreptitiously and steadily embraced the tenets of capitalism, especially since economic reforms were enacted in 1978.

Succeeding Mao, Deng Xiaoping, a Communist Party veteran, was eager to adopt capitalist methods and reforms to try to stimulate economic growth and restore confidence in the party. Deng launched several economic reforms that allowed private sectors to start and operate their own businesses again. He also established four special economic zones along the coast of China with intentions of attracting foreign investments. Due to the reforms Deng put in place, China has gone from being a country that opposed capitalism to one that embraces property rights, profits and free market competition.

Today, China’s economy is the second-largest in the world and is likely to overtake the U.S. sometime this century. The country is in the process of transforming itself from a global center of low-tech manufacturing into a major hub of innovation and consumption.

Computer usage in China has exploded. There are now over 730 million internet users in China and over 95 percent, 695 million+, use mobile devices for internet access. This massive increase of computer users in China creates both challenges and opportunities.

To capture the immense new opportunities in China’s changing consumer market, companies must become more strategic in targeting income segments, product categories, and retail channels. To succeed, it’s imperative that companies take into account rapid shifts in consumer consumption patterns. Serving the businesses that feed Chinese consumer demand, Moxian, Inc. (NASDAQ: MOXC) is poised to profit from the long and vast economic transition in China.

Moxian provides small and medium-sized businesses cutting edge turnkey solutions to attract and maintain customers. The company’s strategy is to drive consumer traffic from online to brick and mortar business customers. Moxian operates a captivating social network which integrates social media and business into a single platform that offers products, features and services that appeal to consumers, keeping them engaged, coming back and even referring new customers.

The company’s online platforms and mobile applications, the Moxian+ User app and the Moxian+ Business app, allow businesses to interface with both existing and new customers. These interactions provide each business the data to analyze consumer likes, dislikes and trends. Moxian’s platform gives businesses the ability to create, manage and promote individualized customer loyalty programs, targeted advertising campaigns and special promotions. These interactions between users and Moxian’s merchant clients give businesses the ability to study consumer behavior and tailor offerings to customers. Moxian is leveraging technology to drive business in the new Chinese consumer economy and offers an opportunity to profit from China’s transformation from communism to consumerism.

For more information, visit www.Moxian.com